Karen Jane Etchberger
Direttore Tecnico/Scientifico/R&S presso SAFC Biosciences, Inc.
Profilo
Karen Jane Etchberger is currently working as a Technical Director at SAFC Biosciences, Inc. and as a Director at Guangzhou Junxin Pharmaceutical Ltd.
Previously, she worked as a Director at Plasma Protein Therapeutics Association from 2013 to 2020 and as an Executive VP-Quality & Business Services at CSL Behring LLC.
She holds a doctorate degree from the University of Maine.
Posizioni attive di Karen Jane Etchberger
Società | Posizione | Inizio |
---|---|---|
SAFC Biosciences, Inc.
SAFC Biosciences, Inc. Pharmaceuticals: MajorHealth Technology SAFC Biosciences, Inc. develops, manufactures, markets cell culture reagents and services targeted for commercial firms involved in developing and producing biopharmaceuticals using mammalian and insect cell culture methods. The company was acquired in 2005 by chemical supplier Sigma Aldrich Corp. The company was founded in 1971 and is headquartered in Lenexa, KA | Direttore Tecnico/Scientifico/R&S | - |
Guangzhou Junxin Pharmaceutical Ltd.
Guangzhou Junxin Pharmaceutical Ltd. Drugstore ChainsRetail Trade Guangzhou Junxin Pharmaceutical Ltd. engages in the sale of Western medicines. Its business activities include medical device and blood product management, and import and export business. The company was founded on September 17, 2003 and is headquartered in Guangzhou, China. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Karen Jane Etchberger
Società | Posizione | Fine |
---|---|---|
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Presidente | - |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - |
Formazione di Karen Jane Etchberger
University of Maine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Commercial Services |
SAFC Biosciences, Inc.
SAFC Biosciences, Inc. Pharmaceuticals: MajorHealth Technology SAFC Biosciences, Inc. develops, manufactures, markets cell culture reagents and services targeted for commercial firms involved in developing and producing biopharmaceuticals using mammalian and insect cell culture methods. The company was acquired in 2005 by chemical supplier Sigma Aldrich Corp. The company was founded in 1971 and is headquartered in Lenexa, KA | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Guangzhou Junxin Pharmaceutical Ltd.
Guangzhou Junxin Pharmaceutical Ltd. Drugstore ChainsRetail Trade Guangzhou Junxin Pharmaceutical Ltd. engages in the sale of Western medicines. Its business activities include medical device and blood product management, and import and export business. The company was founded on September 17, 2003 and is headquartered in Guangzhou, China. | Retail Trade |
- Borsa valori
- Insiders
- Karen Jane Etchberger